Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novartis, Orion’s Stalevo Drug May Have Cancer Risk
Novartis, Orion’s Stalevo Drug May Have Cancer Risk
Novartis, Orion’s Stalevo Drug May Have Cancer Risk
Submitted by
admin
on April 1, 2010 - 9:42am
Source:
Bloomberg
News Tags:
Novartis
Orion
Stalevo
prostate cancer
Parkinson's Disease
Headline:
Novartis, Orion’s Stalevo Drug May Have Cancer Risk
Do Not Allow Advertisers to Use My Personal information